Report ID: UCMIG35B2172
Report ID:
UCMIG35B2172 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
Point-of-Care Testing (POCT) Market is being analyzed by North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA) regions. Key countries including the U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Brazil, GCC Countries, and South Africa among others were analyzed considering various micro and macro trends.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONThe market for Point-of-Care Testing (POCT) was estimated to be valued at US$ XX Mn in 2021.
The Point-of-Care Testing (POCT) Market is estimated to grow at a CAGR of XX% by 2028.
The Point-of-Care Testing (POCT) Market is segmented on the basis of Product Type, Platform, Mode of Purchase, Testing Type, End-User, Geography.
Based on region, the Point-of-Care Testing (POCT) Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the Point-of-Care Testing (POCT) Market are , Sinocare Inc , Hoffmann La Roche Ltd , Siemens AG , Abott Laboratories , bioMrieux SA , Becton Dickinson and Company, Danaher Coraporation, Nova Biomedical, Sysmex corporation, Johnson and Johnson, Biosensor Inc, Fluxergy, Precision, Ascensia Diabetes Care Holding AG, LifeScan IP Holdings, LLC , Mankind pharma , OraSure Technologies, inc , A. Menarini Diagnostics s.r.l , ACON Laboratories , Trinity Biotech plc.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: UCMIG35B2172